A practical reference on GHRH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-23 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
特沙莫瑞林的检测通常依赖反相高效液相色谱和质谱联用。反相色谱可分离肽主峰与缺失序列、氧化产物等杂质，质谱则提供精确质量以确认身份。对于复杂基质中的定量，常采用液相色谱-串联质谱，并配合固相萃取或蛋白沉淀。生物样品中的肽易降解，因此采集和处理条件会影响结果。
稳定性研究通常考察温度、光照、湿度和 pH 对肽链的影响。冻干粉在低温避光条件下较为稳定，复溶后则需控制保存时间并避免反复冻融。肽类可能发生氧化、脱酰胺、水解和聚集，这些变化会改变色谱纯度。强制降解实验用于识别主要降解途径并验证分析方法的专属性。
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Pyridoxal phosphate (PLP, pyridoxal 5'-phosphate, P5P, scientitifically known as 4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate, the active form of vitamin B6, is a coenzyme in a variety of enzymatic reactions. The International Union of Biochemistry and Molecular Biology has catalogued more than 140 PLP-dependent activities, corresponding to ~4% of all classified activities. The versatility of PLP arises from its ability to covalently bind the substrate, and then to act as an electrophilic catalyst, thereby stabilizing different types of carbanionic reaction intermediates.
is the spatial velocity gradient tensor. If only these two original criteria are used to define hypoelasticity, then hyperelasticity would be included as a special case, which prompts some constitutive modelers to append a third criterion that specifically requires a hypoelastic model to not be hyperelastic (i.e., hypoelasticity implies that stress is not derivable from an energy potential). If this third criterion is adopted, it follows that a hypoelastic material might admit nonconservative adiabatic loading paths that start and end with the same deformation gradient but do not start and end at the same internal energy. Note that the second criterion requires only that the function
Blood tests conducted by WADA at the 2004 Olympic Games in Athens, Greece, targeted primarily HGH. Use of the drug for performance enhancement is not currently approved by the FDA. GH has been studied for use in raising livestock more efficiently in industrial agriculture and several efforts have been made to obtain governmental approval to use GH in livestock production. These uses have been controversial. In the United States, the only FDA-approved use of GH for livestock is the use of a cow-specific form of GH called bovine somatotropin for increasing milk production in dairy cows. Retailers are permitted to label containers of milk as produced with or without bovine somatotropin.
Sources: en.wikipedia.org
Conditions in the predominant agricultural sector kept deteriorating between 1929 and 1939, which resulted in rural unrest and a progressive radicalization of the Polish peasant movement that became increasingly inclined toward militant anti-state activities. It was firmly repressed by the authorities. According to Norman Davies, the failures of the Sanation government (combined with the objective economic realities) caused a radicalization of the Polish masses by the end of the 1930s, but he warns against drawing parallels with the incomparably more oppressive Nazi Germany or the Stalinist Soviet Union.
=== Founding and early activity === White Castle was founded 1921 in Wichita, Kansas. Anderson partnered with Ingram to make White Castle into a chain of restaurants and market the brand and its distinctive product. The two men incorporated the business in 1924 and named it White Castle System of Eating Houses Corporation. Anderson and Ingram started with only $700 for the original White Castle in Wichita, Kansas. The original location was the northwest corner of First and Main; the building is no longer standing. After the novel The Jungle by Upton Sinclair had been published in 1906 and exposed the poor sanitation practices of the meat-packing industry, many Americans became wary of eating ground beef. The founders set out to change the public's perception of the cleanliness of the industry they were creating. To invoke a feeling of cleanliness, their restaurants were small buildings with stainless steel interiors, and employees outfitted with spotless uniforms. Their first restaurants in Wichita were a success, and the company branched out into other Midwestern markets, starting in 1922 with El Dorado, Kansas.
== Further reading == Bud, Robert. "Biotechnology in the Twentieth Century." Social Studies of Science 21.3 (1991), 415–457 doi:10.1177/030631291021003002. Bud, Robert (1989). "History of 'biotechnology". Nature. 337 (6202): 10. Bibcode:1989Natur.337...10B. doi:10.1038/337010a0. PMID 2909886. S2CID 4354445. Dronamraju, Krishna R. Biological and Social Issues in Biotechnology Sharing. Brookfield: Ashgate Publishing Company, 1998. ISBN 9781840148978. Feldbaum, Carl (2002). "Some History Should Be Repeated". Science. 295 (5557): 975. doi:10.1126/science.1069614. PMID 11834802. S2CID 32595222. Rasmussen, Nicolas, Gene Jockeys: Life Science and the rise of Biotech Enterprise, Johns Hopkins University Press, (Baltimore), 2014. ISBN 978-1-42141-340-2.
Sources: en.wikipedia.org
Professor Reddi discovered that bone induction is a sequential multistep cascade involving chemotaxis, mitosis, and differentiation. Early studies in his laboratory at the University of Chicago and National Institutes of Health unraveled the sequence of events involved in bone matrix-induce bone morphogenesis. Using a battery of in vitro and in vivo bioassays for bone formation, a systematic study was undertaken in his laboratory to isolate and purify putative bone morphogenetic proteins. Reddi and colleagues were the first to identify BMPs as pleiotropic regulators, acting in a concentration dependent manner. They demonstrated first that BMPs bind the extracellular matrix, are present at the apical ectodermal ridge in the developing limb bud, are chemotactic for human monocytes, and have neurotropic potential. His laboratory pioneered the use of BMPs in regenerative orthopedics and dentistry. Professor Reddi's h-index is 109 with over 300 peer-reviewed manuscripts.
Dmitri Leonidovich Romanowsky (sometimes spelled Dmitry and Romanowski, Russian: Дмитрий Леонидович Романовский; 1861–1921) was a Russian physician who is best known for his invention of an eponymous histological stain called Romanowsky stain. It paved the way for the discovery and diagnosis of microscopic pathogens, such as malarial parasites, and later developments of new histological stains that became fundamental to microbiology and physiology. While working on his doctoral research, Romanowsky developed the first effective staining method for malarial parasite in 1890. Using a specific mixture of mouldy methylene blue and eosin, he found that malarial parasites could be distinctively identified from other blood cell and within the red blood cells. The chemical reaction of such staining is known in chemistry as "Romanowsky effect". The method became the gold standard in malaria detection by microscopy and general immunohistochemistry. British zoologist and science historian, Francis Edmund Gabriel Cox remarked the discovery as a serendipitous case that became "one of the most significant technical advances in the history of parasitology."
As a potential weapon material, pure uranium-233 is more similar to plutonium-239 than uranium-235 in terms of source (bred vs natural), half-life and critical mass (both 4–5 kg in beryllium-reflected sphere). Unlike reactor-bred plutonium, it has a very low spontaneous fission rate, which combined with its low critical mass made it initially attractive for compact gun-type weapons, such as small-diameter artillery shells. A declassified 1966 memo from the US nuclear program stated that uranium-233 has been shown to be highly satisfactory as a weapons material, though it was only superior to plutonium in rare circumstances. It was claimed that if the existing weapons were based on uranium-233 instead of plutonium-239, Livermore would not be interested in switching to plutonium. The co-presence of uranium-232 can complicate the manufacture and use of uranium-233, though the Livermore memo indicates a likelihood that this complication can be worked around. Chuck Hansen wrote in Swords of Armageddon that 233U was evaluated by the United States for its ability to substitute for supergrade plutonium in nuclear weapons. As it was deemed equivalent to plutonium rather than superior to it, military interest in 233U-based weapons waned in the late 1960s. However, several 233U-based nuclear weapons were tested by the US between 1955 and 1968. The Rocky Flats Plant, which refined fissile materials for weapons production, was refining 233U until the early 1980s.
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
反相高效液相色谱用于分离和纯度评估，质谱用于分子量确认。肽图谱或串联质谱可进一步验证序列。具体方法需根据样品基质和监管要求选择。